Neuro-oncology: The long and winding road--gene therapy for glioma.

This publication has 8 references indexed in Scilit:

• Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
  The Lancet Oncology, 2013
• Primary Prevention of Ischaemic Cardiovascular Disorders with Antiplatelet Agents
  Published by Springer Nature ,2012
• Oncolytic Virus Therapy for Glioblastoma Multiforme
  The Cancer Journal, 2012
• Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
  Clinical Cancer Research, 2010
• HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
  PLoS Medicine, 2009
• AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study
  Molecular Therapy, 2004
• A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme
  Human Gene Therapy, 2000
• Thymidine Kinase Gene Therapy for Human Malignant Glioma, Using Replication-Deficient Retroviruses or Adenoviruses
  Human Gene Therapy, 2000